       Document 0732
 DOCN  M9590732
 TI    [Confidentiality in HIV-infection/AIDS--a comment on the Communicable
       Disease Control Act]
 DT    9509
 AU    Frich JC
 SO    Tidsskr Nor Laegeforen. 1995 May 10;115(12):1521-3. Unique Identifier :
       AIDSLINE MED/95288727
 AB    The new Communicable Diseases Control Act has come into force in Norway.
       It makes it compulsory for a physician to warn a third party if it is
       obvious that a HIV-positive patient, with a high degree of certainty,
       puts the third party at risk of being infected with HIV. Some
       philosophers characterize medical confidentiality as an intransigent and
       absolute obligation, others as a prima facie duty. This article supports
       the latter view, but the author still argues that strict conditions have
       to be fulfilled before a physician should consider breaking medical
       confidentiality: The doctor must try repeatedly to gain the consent or
       co-operation of the patient involved. Possible negative long-term
       consequences for the preventive HIV-work support strict medical
       confidentiality.
 DE    *Acquired Immunodeficiency Syndrome/EPIDEMIOLOGY/PREVENTION &
       CONTROL/PSYCHOLOGY  Communicable Disease Control/*LEGISLATION &
       JURISPRUD  *Confidentiality  English Abstract  Ethics, Medical  Human
       *HIV Infections/EPIDEMIOLOGY/PREVENTION & CONTROL/PSYCHOLOGY  HIV
       Seropositivity/EPIDEMIOLOGY/PSYCHOLOGY  Norway/EPIDEMIOLOGY  JOURNAL
       ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

